AEterna Zentaris Price to Book Ratio 2006-2019 | AEZS

Historical price to book ratio values for AEterna Zentaris (AEZS) over the last 10 years. The current price to book ratio for AEterna Zentaris as of November 12, 2019 is 0.00.
AEterna Zentaris Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2019-11-12 1.03 0.00
2019-09-30 1.03 $-0.11 -9.39
2019-06-30 2.95 $-0.18 -16.20
2019-03-31 4.65 $-0.22 -21.48
2018-12-31 2.94 $0.12 25.34
2018-06-30 1.95 $0.58 3.37
2018-03-31 1.46 $0.70 2.08
2017-12-31 2.36 $-0.17 -13.94
2017-09-30 2.03 $-0.12 -17.07
2017-06-30 1.00 $0.31 3.26
2017-03-31 3.00 $0.39 7.74
2016-12-31 3.60 $0.48 7.49
2016-09-30 3.44 $0.33 10.58
2016-06-30 3.26 $0.91 3.58
2016-03-31 3.32 $1.64 2.02
2015-12-31 4.48 $2.18 2.06
2015-09-30 8.80 0.00
2015-06-30 28.10 0.00
2015-03-31 53.62 0.00
2014-12-31 60.00 $22.11 2.71
2014-09-30 134.00 0.00
2014-06-30 116.10 0.00
2014-03-31 117.00 0.00
2013-12-31 138.00 0.00
2013-09-30 151.00 0.00
2013-06-30 186.00 0.00
2013-03-31 188.00 0.00
2012-12-31 238.00 0.00
2012-09-30 420.00 0.00
2012-06-30 303.00 0.00
2012-03-31 1284.00 0.00
2011-12-31 924.00 0.00
2011-09-30 912.00 0.00
2011-06-30 1320.00 0.00
2011-03-31 1164.00 0.00
2010-12-31 1032.00 0.00
2010-09-30 780.00 0.00
2010-06-30 690.00 0.00
2010-03-31 474.00 0.00
2009-12-31 484.14 0.00
2009-09-30 732.00 0.00
2009-06-30 1038.00 0.00
2009-03-31 528.00 0.00
2008-12-31 294.00 0.00
2008-09-30 354.00 0.00
2008-06-30 630.00 0.00
2008-03-31 618.00 0.00
2007-12-31 924.00 0.00
2007-09-30 1572.00 0.00
2007-06-30 2076.00 0.00
2007-03-31 2274.00 0.00
2006-12-31 2430.00 0.00
2006-09-30 3078.00 0.00
2006-06-30 3600.00 0.00
2006-03-31 3978.00 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.021B $0.027B
AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead oncology program is a Phase 2 trial in endometrial and ovarian cancer with AEZS-108, a targeted cytotoxic peptide conjugate. Other lead compounds include ozarelix for BPH and prostate cancer as well as perifosine for multiple cancers.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.136B 15.11
CSL (CSLLY) Australia $84.078B 0.00
Gilead Sciences (GILD) United States $81.779B 10.13
Celgene (CELG) United States $77.983B 11.14
Biogen (BIIB) United States $53.075B 9.11
Vertex Pharmaceuticals (VRTX) United States $51.919B 52.99
Illumina (ILMN) United States $43.365B 47.58
Regeneron Pharmaceuticals (REGN) United States $37.813B 16.55
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.123B 11.91
Seattle Genetics (SGEN) United States $18.561B 0.00
Incyte (INCY) United States $18.279B 42.43
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.254B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.531B 0.00
Genmab (GNMSF) Denmark $13.346B 74.86
Exact Sciences (EXAS) United States $10.455B 0.00
Galapagos (GLPG) Belgium $10.396B 26.78
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.307B 0.00
BeiGene (BGNE) Cayman Islands $9.103B 0.00
Bio-Techne Corp (TECH) United States $7.739B 51.80
QIAGEN (QGEN) Netherlands $7.300B 23.80
Sarepta Therapeutics (SRPT) United States $7.065B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.968B 0.00
Guardant Health (GH) United States $6.784B 0.00
Reata Pharmaceuticals (RETA) United States $6.433B 0.00
Amarin (AMRN) Ireland $6.040B 0.00
Moderna (MRNA) United States $5.799B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.621B 14.29
ARGENX SE-ADR (ARGX) Netherlands $4.843B 0.00
Ascendis Pharma (ASND) Denmark $4.773B 0.00
Exelixis (EXEL) United States $4.725B 13.29
China Biologic Products (CBPO) China $4.545B 28.37
Medicines (MDCO) United States $4.414B 0.00
Spark Therapeutics (ONCE) United States $4.287B 0.00
Repligen (RGEN) United States $4.281B 77.58
Mirati Therapeutics (MRTX) United States $4.069B 0.00
Bluebird Bio (BLUE) United States $4.037B 0.00
Adaptive Biotechnologies (ADPT) United States $3.520B 0.00
Blueprint Medicines (BPMC) United States $3.492B 0.00
MorphoSys AG (MOR) Germany $3.378B 0.00
Immunomedics (IMMU) United States $3.326B 0.00
Alkermes (ALKS) Ireland $3.130B 0.00
Genmab (GMAB) Denmark $2.853B 5.88
CRISPR Therapeutics AG (CRSP) Switzerland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.775B 27.56
Intercept Pharmaceuticals (ICPT) United States $2.683B 0.00
MyoKardia (MYOK) United States $2.563B 0.00
Halozyme Therapeutics (HALO) United States $2.429B 0.00
NeoGenomics (NEO) United States $2.378B 127.22
Acceleron Pharma (XLRN) United States $2.366B 0.00
Amicus Therapeutics (FOLD) United States $2.363B 0.00
UniQure (QURE) Netherlands $2.344B 0.00
Arena Pharmaceuticals (ARNA) United States $2.306B 5.40
Zai Lab (ZLAB) China $2.289B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.166B 0.00
Ligand Pharmaceuticals (LGND) United States $2.070B 36.79
Cambrex (CBM) United States $2.016B 25.44
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Myriad Genetics (MYGN) United States $1.803B 26.64
Insmed (INSM) United States $1.690B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.583B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.467B 0.00
Denali Therapeutics (DNLI) United States $1.426B 0.00
REGENXBIO (RGNX) United States $1.418B 0.00
Zymeworks (ZYME) Canada $1.369B 0.00
Epizyme (EPZM) United States $1.353B 0.00
Coherus BioSciences (CHRS) United States $1.312B 0.00
Innoviva (INVA) United States $1.238B 3.65
Dicerna Pharmaceuticals (DRNA) United States $1.227B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.153B 0.00
Alector (ALEC) United States $1.148B 0.00
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Sangamo Therapeutics (SGMO) United States $1.134B 0.00
Fate Therapeutics (FATE) United States $1.096B 0.00
Zealand Pharma (ZEAL) Denmark $1.044B 11.72
Editas Medicine (EDIT) United States $1.010B 0.00
WAVE Life Sciences (WVE) Singapore $0.926B 0.00
Codexis (CDXS) United States $0.894B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.889B 0.00
Athenex (ATNX) United States $0.880B 0.00
Arvinas (ARVN) United States $0.868B 0.00
Anika Therapeutics (ANIK) United States $0.859B 27.88
Vericel (VCEL) United States $0.856B 319.17
Cara Therapeutics (CARA) United States $0.851B 0.00
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.794B 6.67
Principia Biopharma (PRNB) United States $0.768B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.760B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.734B 0.00
Twist Bioscience (TWST) United States $0.716B 0.00
Heska (HSKA) United States $0.700B 178.74
DBV Technologies S.A (DBVT) France $0.699B 0.00
ANI Pharmaceuticals (ANIP) United States $0.694B 11.83
Revance Therapeutics (RVNC) United States $0.682B 0.00
MiMedx (MDXG) United States $0.649B 0.00
Intellia Therapeutics (NTLA) United States $0.634B 0.00
GENFIT S.A (GNFT) France $0.630B 0.00
Mesoblast (MESO) Australia $0.618B 0.00
Adverum Biotechnologies (ADVM) United States $0.591B 0.00
Cellectis S.A (CLLS) France $0.576B 0.00
Retrophin (RTRX) United States $0.549B 0.00
Agenus (AGEN) United States $0.536B 0.00
BioDelivery Sciences (BDSI) United States $0.523B 0.00
Intra-Cellular Therapies (ITCI) United States $0.514B 0.00
UROGEN PHARMA (URGN) United States $0.506B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.491B 0.00
Cytokineticsorporated (CYTK) United States $0.482B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
PHARMA MAR SA (PHMMF) Spain $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Precision BioSciences (DTIL) United States $0.431B 0.00
Stemline Therapeutics (STML) United States $0.429B 0.00
Kadmon Holdings (KDMN) United States $0.388B 0.00
AC Immune SA (ACIU) Switzerland $0.382B 28.30
Lexicon Pharmaceuticals (LXRX) United States $0.377B 2.61
Merus (MRUS) Netherlands $0.375B 0.00
Dynavax Technologies (DVAX) United States $0.369B 0.00
Prothena (PRTA) Ireland $0.365B 0.00
Bellus Health (BLU) Canada $0.358B 0.00
Arcus Biosciences (RCUS) United States $0.350B 0.00
Cellular Biomedicine (CBMG) United States $0.345B 0.00
Puma Biotechnology (PBYI) United States $0.332B 0.00
PDL BioPharma (PDLI) United States $0.331B 8.29
Pfenex (PFNX) United States $0.331B 0.00
Kindred Biosciences (KIN) United States $0.330B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.314B 0.00
Theratechnologies (THTX) Canada $0.302B 0.00
Geron (GERN) United States $0.296B 0.00
Clovis Oncology (CLVS) United States $0.295B 0.00
Protagonist Therapeutics (PTGX) United States $0.287B 0.00
Avid Bioservices (CDMO) United States $0.286B 0.00
AnaptysBio (ANAB) United States $0.281B 0.00
Compugen (CGEN) Israel $0.279B 0.00
Gritstone Oncology (GRTS) United States $0.268B 0.00
Scholar Rock Holding (SRRK) United States $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.255B 0.00
CytomX Therapeutics (CTMX) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
Sutro Biopharma (STRO) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.243B 0.00
Cel-Sci (CVM) United States $0.240B 0.00
MannKind (MNKD) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Sorrento Therapeutics (SRNE) United States $0.223B 0.00
Kamada (KMDA) Israel $0.215B 8.23
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.212B 0.00
Syros Pharmaceuticals (SYRS) United States $0.212B 0.00
Cue Biopharma (CUE) United States $0.206B 0.00
Athersys (ATHX) United States $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.201B 0.00
OSMOTICA PHARM (OSMT) United States $0.198B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Exicure (XCUR) United States $0.186B 0.00
Palatin Technologies (PTN) United States $0.185B 5.43
Senesco Technologies (ELOX) United States $0.180B 0.00
Arsanis (XFOR) United States $0.177B 0.00
ChromaDex (CDXC) United States $0.170B 0.00
Affimed (AFMD) Germany $0.162B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.144B 0.00
Five Prime Therapeutics (FPRX) United States $0.143B 0.00
Ophthotech (ISEE) United States $0.141B 0.00
CorMedix Inc (CRMD) United States $0.140B 0.00
Alcobra (ARCT) United States $0.139B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.138B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
Enzo Biochem (ENZ) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.126B 0.00
Abeona Therapeutics (ABEO) United States $0.123B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Menlo Therapeutics (MNLO) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
NantKwest (NK) United States $0.112B 0.00
PHASEBIO PHARMA (PHAS) United States $0.111B 0.00
Aptinyx (APTX) United States $0.111B 0.00
BioTime (LCTX) United States $0.109B 7.30
Mersana Therapeutics (MRSN) United States $0.107B 0.00
Acorda Therapeutics (ACOR) United States $0.105B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
Novavax (NVAX) United States $0.104B 0.00
OvaScience (MLND) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.093B 2.48
Antibe Therapeutics (ATBPF) Canada $0.091B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Celyad SA (CYAD) Belgium $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.084B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.082B 0.00
Verastem (VSTM) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
Trevena (TRVN) United States $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Orgenesis (ORGS) United States $0.056B 3.65
Pluristem Therapeutics (PSTI) Israel $0.053B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Merrimack Pharmaceuticals (MACK) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.051B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Unum Therapeutics (UMRX) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.034B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.95
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Celsion (CLSN) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.021B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Alimera Sciences (ALIM) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00